Kuroiwa Y - Search Results

1

The use of chromosome-based vectors for animal transgenesis.

Kuroiwa Y, Yoshida H, Ohshima T, Shinohara T, Ohguma A, Kazuki Y, Oshimura M, Ishida I, Tomizuka K. Kuroiwa Y, et al. Gene Ther. 2002 Jun;9(11):708-12. doi: 10.1038/sj.gt.3301754. Gene Ther. 2002. PMID: 12032693

2

Manipulation of human minichromosomes to carry greater than megabase-sized chromosome inserts.

Kuroiwa Y, Tomizuka K, Shinohara T, Kazuki Y, Yoshida H, Ohguma A, Yamamoto T, Tanaka S, Oshimura M, Ishida I. Kuroiwa Y, et al. Nat Biotechnol. 2000 Oct;18(10):1086-90. doi: 10.1038/80287. Nat Biotechnol. 2000. PMID: 11017048

3

Human artificial chromosome (HAC) vector provides long-term therapeutic transgene expression in normal human primary fibroblasts.

Kakeda M, Hiratsuka M, Nagata K, Kuroiwa Y, Kakitani M, Katoh M, Oshimura M, Tomizuka K. Kakeda M, et al. Among authors: kuroiwa y. Gene Ther. 2005 May;12(10):852-6. doi: 10.1038/sj.gt.3302483. Gene Ther. 2005. PMID: 15750614

4

Efficient modification of a human chromosome by telomere-directed truncation in high homologous recombination-proficient chicken DT40 cells.

Kuroiwa Y, Shinohara T, Notsu T, Tomizuka K, Yoshida H, Takeda S, Oshimura M, Ishida I. Kuroiwa Y, et al. Nucleic Acids Res. 1998 Jul 15;26(14):3447-8. doi: 10.1093/nar/26.14.3447. Nucleic Acids Res. 1998. PMID: 9649633 Free PMC article.

5

Artificial chromosome vectors and expression of complex proteins in transgenic animals.

Robl JM, Kasinathan P, Sullivan E, Kuroiwa Y, Tomizuka K, Ishida I. Robl JM, et al. Among authors: kuroiwa y. Theriogenology. 2003 Jan 1;59(1):107-13. doi: 10.1016/s0093-691x(02)01262-1. Theriogenology. 2003. PMID: 12499022 Review.

6

Transgenic animal production and animal biotechnology.

Robl JM, Wang Z, Kasinathan P, Kuroiwa Y. Robl JM, et al. Among authors: kuroiwa y. Theriogenology. 2007 Jan 1;67(1):127-33. doi: 10.1016/j.theriogenology.2006.09.034. Epub 2006 Oct 27. Theriogenology. 2007. PMID: 17070901 Review.

7

Bufalin inhibits endothelial cell proliferation and angiogenesis in vitro.

Lee DY, Yasuda M, Yamamoto T, Yoshida T, Kuroiwa Y. Lee DY, et al. Among authors: kuroiwa y. Life Sci. 1997;60(2):127-34. doi: 10.1016/s0024-3205(96)00602-9. Life Sci. 1997. PMID: 9000118

8

Improved highly sensitive method for determination of nicotine and cotinine in human plasma by high-performance liquid chromatography.

Nakajima M, Yamamoto T, Kuroiwa Y, Yokoi T. Nakajima M, et al. Among authors: kuroiwa y. J Chromatogr B Biomed Sci Appl. 2000 May 26;742(1):211-5. doi: 10.1016/s0378-4347(00)00149-3. J Chromatogr B Biomed Sci Appl. 2000. PMID: 10892601

9

Diastereospecific kinetics of nicotine N'-oxidation in rat liver microsomes.

Nakajima M, Iwata K, Yoshida T, Yamamoto T, Kuroiwa Y. Nakajima M, et al. Among authors: kuroiwa y. Xenobiotica. 1998 Feb;28(2):127-35. doi: 10.1080/004982598239632. Xenobiotica. 1998. PMID: 9522438

10

Deficient cotinine formation from nicotine is attributed to the whole deletion of the CYP2A6 gene in humans.

Nakajima M, Yamagishi S, Yamamoto H, Yamamoto T, Kuroiwa Y, Yokoi T. Nakajima M, et al. Among authors: kuroiwa y. Clin Pharmacol Ther. 2000 Jan;67(1):57-69. doi: 10.1067/mcp.2000.103957. Clin Pharmacol Ther. 2000. PMID: 10668854 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

950 results

Search Page

Filters